BROWN RYAN EDWARD (SVP, General Counsel) sold 69.5% of their position (38.96K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.30M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+6.25K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−2.35K
Price / share
$164.64
Trade value
$387.23K
% of position
Common Stock
Shares
+23.50K
Price / share
$62.77
Trade value
$1.48M
% of position
Common Stock
Shares
−7.64K
Price / share
$158.07
Trade value
$1.21M
% of position
Common Stock
Shares
−2.20K
Price / share
$159.14
Trade value
$350.11K
% of position
Common Stock
Shares
−975.00
Price / share
$160.31
Trade value
$156.30K
% of position
Common Stock
Shares
−4.17K
Price / share
$161.82
Trade value
$674.47K
% of position
Common Stock
Shares
−17.58K
Price / share
$162.65
Trade value
$2.86M
% of position
Common Stock
Shares
−3.84K
Price / share
$163.53
Trade value
$627.96K
% of position
Common Stock
Shares
−2.55K
Price / share
$164.52
Trade value
$419.36K
% of position
Net shares
−11.56K
Net value
-$5.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2024 | M · Option Exercise | +6.25K | — | — | 21.8% | 28.69K | 34.94K |
| Common Stock Direct | 6/24/2024 | F · Tax Withholding | −2.35K | $164.64 | $387.23K | 6.7% | 34.94K | 32.59K |
| Common Stock Direct | 6/25/2024 | M · Option Exercise | +23.50K | $62.77 | $1.48M | 72.1% | 32.59K | 56.09K |
| Common Stock Direct | 6/25/2024 | S · Sale | −7.64K | $158.07 | $1.21M | 13.6% | 56.09K | 48.44K |
| Common Stock Direct | 6/25/2024 | S · Sale | −2.20K | $159.14 | $350.11K | 4.5% | 48.44K | 46.24K |
| Common Stock Direct | 6/25/2024 | S · Sale | −975.00 | $160.31 | $156.30K | 2.1% | 46.24K | 45.27K |
| Common Stock Direct | 6/25/2024 | S · Sale | −4.17K | $161.82 | $674.47K | 9.2% | 45.27K | 41.10K |
| Common Stock Direct | 6/25/2024 | S · Sale | −17.58K | $162.65 | $2.86M | 42.8% | 41.10K | 23.52K |
| Common Stock Direct | 6/25/2024 | S · Sale | −3.84K | $163.53 | $627.96K | 16.3% | 23.52K | 19.68K |
| Common Stock Direct | 6/25/2024 | S · Sale | −2.55K | $164.52 | $419.36K | 13.0% | 19.68K | 17.13K |
| Total | −11.56K | -$5.21M | ||||||
Performance Stock Units
Common Stock
5.50K shares
Shares
+5.50K
Strike price
Held after
5.50K
Exercisable
—
Performance Stock Units
Common Stock
6.25K shares
Shares
+6.25K
Strike price
Held after
6.25K
Exercisable
—
Performance Stock Units
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
23.50K shares
Shares
−23.50K
Strike price
62.77
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock5.50K shares | 6/21/2024 | A · Award | +5.50K | — | 5.50K | |
| Performance Stock Units Direct | Common Stock6.25K shares | 6/21/2024 | A · Award | +6.25K | — | 6.25K | |
| Performance Stock Units Direct | Common Stock6.25K shares | 6/21/2024 | M · Option Exercise | −6.25K | — | 0.00 | |
| Stock Option (right to buy) Direct | Common Stock23.50K shares | 6/25/2024 | M · Option Exercise | −23.50K | 62.77 | — | 0.00 |